Nicholas Warren PhD

I serve as the Assistant Director of Federal Relations for Vanderbilt University Medical Center. Views expressed are my own

[Rep. Matt Van Epps @repvanepps]

Honored that my first meeting in D.C. was with the Children’s Hospital Alliance of Tennessee. Their commitment to caring for our state’s children is remarkable, and I look forward to supporting their mission in Congress.

[Nicholas Warren PhD @WarrenNJH]

Last week I had the honor of leading the Tennessee group for the Rally for Medical Research. We had a fantastic group of researchers and patient advocates. Medical research saves lives! #FundNIH #RallyMedRes

https://t.co/fmT20BznBf

[AACR @AACR]

A recent @CCR_AACR perspective discussed how to improve collection and analysis of #OverallSurvival data in oncology clinical trials. @WarrenNJH breaks down the key lessons on the #AACRBlog: https://t.co/O113BY0bEW
#AACRSciencePolicy

[AACR @AACR]

A recent @CCR_AACR perspective discussed how to improve collection and analysis of #OverallSurvival data in oncology clinical trials. A new Cancer Research Catalyst blog by @WarrenNJH breaks down the key lessons: https://t.co/FBzZytgZMp
#AACRSciencePolicy

[FDA Oncology @FDAOncology]

In a new @CCR_AACR paper, FDA's Lisa Rodriguez, Nicole Gormley and colleagues share best practices, propose novel statistical methodologies, and provide recommendations to improve the rigor of using #OverallSurvival data to inform benefit-risk assessments.
https://t.co/dWqVQpbf0S

[Nicholas Warren PhD @WarrenNJH]

Proud to have helped support this new @CCR_AACR article on #OverallSurvival! A wonderful and collaborative experience with my colleagues to try to improve the quality and timeliness of trial data!

[AACR @AACR]

A new @CCR_AACR article by @FDAOncology, AACR, and @AmstatNews experts details how to improve the collection and analysis of #OverallSurvival data to better understand the risks and benefits of new therapies. Read the paper: https://t.co/ltYoVdzFuW
#AACRSciencePolicy

[FDA Oncology @FDAOncology]

Applications for the 2024-25 FDA-@AACR Oncology Educational Fellowship are due Aug 14. Early-career cancer investigators or clinicians with an advanced degree (DO, MD, PhD, etc.) within the past 10 years encouraged to apply.
https://t.co/Bxr5YGdaLK
#MedEd #ODACOdyssey

[Nicholas Warren PhD @WarrenNJH]

This is an excellent opportunity to learn about the drug development and regulatory processes from FDA experts!

[AACR @AACR]

The FDA-AACR Oncology Educational Fellowship provides early-career scientists and clinicians with an opportunity to learn more about drug development and the regulatory review process from @FDAOncology and AACR experts. Apply by Aug 1:
https://t.co/JhGWNE4bya
#AACRSciencePolicy

[Christine Lovly, MD, PhD, FASCO @christine_lovly]

⬇️ Starting now!
@US_FDA Center for Tobacco Products’ Prioroties to Reduce Tobacco Use and Support the #Cancer Moonshot
Room 5, second floor.
#AACR24 @AACR @bentollphd

[AACR @AACR]

Ruixiao Lu of the American Statistical Association, @AmStatNews, moderated a panel discussion on @FDAOncology's Project Endpoint and overall survival at #AACR24 today. #AACRSciencePolicy

[AACR @AACR]

.@DrRoyHerbstYale will moderate an #AACRSciencePolicy session to showcase the reignited #CancerMoonshot. @NCIDirector Kimryn Rathmell and other panelists will discuss how we can achieve meaningful progress to “end cancer as we know it.” https://t.co/C3CwKfc1Gb #AACRSciencePolicy

[Nicholas Warren PhD @WarrenNJH]

This is a really exciting #AACR24 session on policies to address the number one cause of cancer, #Tobacco, on Monday at 10:15am PT. Please join us! #AACRSciencePolicy

[AACR @AACR]

Brian King, director of the FDA Center for Tobacco Products, will discuss the center's new strategic plan and other policy initiatives to address #tobacco-related illness in a special #AACRSciencePolicy session at #AACR24. Learn more: https://t.co/A4EkCO8NP0 @FDATobacco

[Nicholas Warren PhD @WarrenNJH]

Please join us for this great #AACR24 session on overall survival this Saturday! #AACRSciencePolicy

[AACR @AACR]

FDA's Project Endpoint and Overall Survival in Oncology Clinical Trials: Ruixiao Lu will moderate an @FDA_Oncology session on this topic during #AACR24. Learn more: https://t.co/u5JSlkPggL
#AACRSciencePolicy

[Manju George MVSc PhD @manjuggm]

Session information here👇👇👇
#AACR24 @AACR #PrecisionMedicine

[AACR @AACR]

A proposed @FDA rule would classify laboratory-developed tests as medical devices subject to regulatory oversight. @DrTonyLetai will moderate an #AACR24 discussion of the benefits and challenges of this new regulatory framework. https://t.co/JYSalQvqjn
#AACRSciencePolicy

[AACR @AACR]

#MCED assays are a promising tool for #earlydetection of cancer, but questions remain about risk assessment in multi-cancer settings and use in clinical practice. Lauren Leiman will moderate an #AACR24 discussion of the future of MCED. https://t.co/CJzDa1TlAe
#AACRSciencePoilcy

[AACR @AACR]

Today is the AACR Early-Career National Day of Action, and we're calling on early-career scientists, trainees, students, and all who support them to contact members of Congress and ask them to prioritize @NIH funding. Take action: https://t.co/Lo1wR2a4fu #AACRontheHill #FundNIH

[Nicholas Warren PhD @WarrenNJH]

Thank you to everyone who made this event a success! #AACRSciencePolicy

[AACR @AACR]

Thanks to everyone who participated in today's @US_FDA_Oncology-AACR Workshop on Optimizing Dosages for Oncology Drug Products. Session recordings and slides will be posted to the AACR website by Thursday, February 22. Learn more: https://t.co/DUcYs1jyq6 #AACRSciencePolicy

[AACR @AACR]

Thanks to everyone who participated in today's @US_FDA_Oncology-AACR Workshop on Optimizing Dosages for Oncology Drug Products. Session recordings and slides will be posted to the AACR website by Thursday, February 22. Learn more: https://t.co/DUcYs1jyq6 #AACRSciencePolicy

[AACR @AACR]

AACR President-Elect Patricia M. LoRusso moderated a panel discussion on lessons learned and next steps to close out the @US_FDA-AACR dosage optimization workshop. We thank the moderators, speakers, and panelists, for their contributions to this vital event. #AACRSciencePolicy